More than half of all deaths among end stage renal disease (ESRD) patients are due to
cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction …

Background Incremental dialysis may preserve residual renal function and improve survival
in comparison with full-dose dialysis; however, available evidence is limited. We therefore …

Safety concerns with erythropoietin analogues and intravenous (IV) iron for treatment of
anemia in CKD necessitate development of safer therapies. Roxadustat (FG-4592) is an …

Results In total, 107 patients chose CM, and 204 chose RRT. Patients choosing CM were
older (mean±SD: 83±4.5 versus 76±4.4 years; P< 0.001). The Davies comorbidity scores did …

Results Most biomarkers were elevated compared with reference values and–—except for
albumin, ferritin, and IGF-1—higher in patients with CVD. In receiver operating characteristic …

Background: As one of the main complications of chronic kidney disease (CKD), the
incidence of cardiovascular disease (CVD) in CKD patients is high. CVD risk is markedly …

Patients with severely decreased glomerular filtration rate (GFR)(ie, chronic kidney disease
[CKD] G4+) are at increased risk for kidney failure, cardiovascular disease (CVD) events …

Chronic kidney disease is present in almost 10% of the world population and is associated
with excess mortality and morbidity. Reduced glomerular filtration rate and the presence and …

Haemodialysis is a life-saving renal replacement modality for end-stage renal disease, but
this therapy also represents a major challenge to the intravascular innate immune system …

As kidney disease progresses, patients often experience a variety of symptoms. A challenge
for the nephrologist is to help determine if these symptoms are related to advancing CKD or …